Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Lymphotropic nanoparticle-enhanced magnetic resonance imaging identifies occult lymph node metastases in prostate cancer patients prior to salvage radiation therapy
Clinical Imaging, 06/26/09
Ross RW et al. - Twenty-six patients with prostate cancer status post-radical prostatectomy who were candidates for salvage radiation therapy underwent lymphotropic nanoparticle enhanced MRI using superparamagnetic nanoparticle ferumoxtran-10. LNMRI was well tolerated, with only two adverse events, both Grade 2. Six of the 26 patients, previously believed to be node negative, tested lymph node positive by LNMRI. A total of nine positive lymph nodes were identified in these six patients, none of which were enlarged based on size criteria.
Today in MRI...keeping you current
Receive free subspecialty "5-minute updates" via email
Effects of High-Dose Modified-Release Nicotinic Acid on Atherosclerosis and Vascular Function: A Randomized, Placebo-Controlled, Magnetic Resonance Imaging Study
JACC - Journal of the American College of Cardiology, 10/29/09
Low-field magnetic resonance imaging for rheumatoid athritis
Zeitschrift für Rheumatologie, 11/13/09
Magnetic Resonance Imaging of the Lumbosacral Spine in Children with Chronic Constipation or Non-retentive Fecal Incontinence
The Journal of Pediatrics, 11/09/09
Today in Radiotherapy (XRT)...keeping you current
Receive free subspecialty "5-minute updates" via email
Radiation therapy and tamoxifen after breast-conserving surgery: Updated results of a 2×2 randomised clinical trial in patients with low risk of recurrence
European Journal of Cancer, 11/05/09
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
The Lancet Oncology - Online First, 11/11/09
Phase I dose-finding study of paclitaxel with panitumumab, carboplatin and intensity-modulated radiotherapy in patients with locally advanced squamous cell cancer of the head and neck
Annals of Oncology, 11/10/09
Sponsor
Article Search
Sponsor


See Latest Articles


